Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia
Completed · Not applicable
Conditions studied: Fanconi's Anemia
In brief
OBJECTIVES: I. Determine the effectiveness of moderate dose cyclophosphamide and total lymphoid radiotherapy in terms of improving the survival and reducing the morbidity following allogeneic bone marrow transplantation in patients with Fanconi's aplastic anemia.
Key facts
- Study ID
- NCT00005891
- Run by
- Fairview University Medical Center
- Starts
- 2000-03-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: any, up to 54. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Fairview University Medical Center — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.